- Home
- Publications
- Publication Search
- Publication Details
Title
Immunomodulatory cytokines as therapeutic agents for melanoma
Authors
Keywords
-
Journal
Immunotherapy
Volume 3, Issue 5, Pages 673-690
Publisher
Future Medicine Ltd
Online
2011-05-10
DOI
10.2217/imt.11.45
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phase III multi-institutional randomized study of immunization with the gp100: 209–217(210M) peptide followed by high-dose IL-2 compared with high-dose IL-2 alone in patients with metastatic melanoma
- (2017) D. J. Schwartzentruber et al. JOURNAL OF CLINICAL ONCOLOGY
- Cytotoxic T lymphocyte-associated antigen 4 blockade with ipilimumab: Long-term follow-up of 179 patients with metastatic melanoma.
- (2017) P. A. Prieto et al. JOURNAL OF CLINICAL ONCOLOGY
- Cutting Edge: Enhanced IL-2 Signaling Can Convert Self-Specific T Cell Response from Tolerance to Autoimmunity
- (2014) Jason Waithman et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: Priming of NK Cells by IL-18
- (2014) J. Chaix et al. JOURNAL OF IMMUNOLOGY
- Interleukin-18: Biology and Role in the Immunotherapy of Cancer
- (2012) S. Srivastava et al. CURRENT MEDICINAL CHEMISTRY
- Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival
- (2011) Jonathan R. Brody et al. CELL CYCLE
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Novel Gamma-Chain Cytokines as Candidate Immune Modulators in Immune Therapies for Cancer
- (2010) Natasha M. Fewkes et al. CANCER JOURNAL
- Immature Immunosuppressive CD14+HLA-DR−/low Cells in Melanoma Patients Are Stat3hi and Overexpress CD80, CD83, and DC-Sign
- (2010) Isabel Poschke et al. CANCER RESEARCH
- Safety and Clinical Effect of Subcutaneous Human Interleukin-21 in Patients with Metastatic Melanoma or Renal Cell Carcinoma: A Phase I Trial
- (2010) H. Schmidt et al. CLINICAL CANCER RESEARCH
- Interferon-β-1b
- (2010) Greg L. Plosker CNS DRUGS
- Interleukin-21: updated review of Phase I and II clinical trials in metastatic renal cell carcinoma, metastatic melanoma and relapsed/refractory indolent non-Hodgkin's lymphoma
- (2010) Mehmood H Hashmi et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen-positive chronic hepatitis B using on-treatment hepatitis B surface antigen decline
- (2010) Milan J. Sonneveld et al. HEPATOLOGY
- Antimelanoma immunotherapy: clinical and preclinical applications of IL-12 family members
- (2010) Hiroshi Nagai et al. Immunotherapy
- Efficacy of Low-Dose Interferon α2a 18 Versus 60 Months of Treatment in Patients With Primary Melanoma of ≥ 1.5 mm Tumor Thickness: Results of a Randomized Phase III DeCOG Trial
- (2010) Axel Hauschild et al. JOURNAL OF CLINICAL ONCOLOGY
- Cytokine Working Group Study of Lymphodepleting Chemotherapy, Interleukin-2, and Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Metastatic Melanoma: Clinical Outcomes and Peripheral-Blood Cell Recovery
- (2010) Krishna S. Gunturu et al. JOURNAL OF CLINICAL ONCOLOGY
- Characterization of Cytokine-Induced Myeloid-Derived Suppressor Cells from Normal Human Peripheral Blood Mononuclear Cells
- (2010) M. G. Lechner et al. JOURNAL OF IMMUNOLOGY
- Interferons Induce CXCR3-cognate Chemokine Production by Human Metastatic Melanoma
- (2010) Lynn T. Dengel et al. JOURNAL OF IMMUNOTHERAPY
- A phase 2, randomized study of SB-485232, rhIL-18, in patients with previously untreated metastatic melanoma
- (2009) Ahmad A. Tarhini et al. CANCER
- Cutaneous Melanoma Is Related to Immune Suppression in Kidney Transplant Recipients
- (2009) C. M. Vajdic et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Ex vivo expansion of tumor specific lymphocytes with IL-15 and IL-21 for adoptive immunotherapy in melanoma
- (2009) Eduardo Huarte et al. CANCER LETTERS
- Cytokines in the Management of High Risk or Advanced Breast Cancer: An Update and Expectation
- (2009) A. Carpi et al. CURRENT CANCER DRUG TARGETS
- Adoptive cell therapy for the treatment of patients with metastatic melanoma
- (2009) Steven A Rosenberg et al. CURRENT OPINION IN IMMUNOLOGY
- Interleukin-21 restrains tumor growth and induces a substantial increase in the number of circulating tumor-specific T cells in a murine model of malignant melanoma
- (2009) Charlotte Christie Petersen et al. CYTOKINE
- A phosphorylation-acetylation switch regulates STAT1 signaling
- (2009) O. H. Kramer et al. GENES & DEVELOPMENT
- Interleukins and cancer immunotherapy
- (2009) Takayuki Yoshimoto et al. Immunotherapy
- Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation in Resected Stage III Melanoma: A Phase III Randomized Controlled Trial of Health-Related Quality of Life and Symptoms by the European Organisation for Research and Treatment of Cancer Melanoma Group
- (2009) Andrew Bottomley et al. JOURNAL OF CLINICAL ONCOLOGY
- Serum Vascular Endothelial Growth Factor and Fibronectin Predict Clinical Response to High-Dose Interleukin-2 Therapy
- (2009) Marianna Sabatino et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Interferon in High-Risk Melanoma: End of the Era?
- (2009) Filip Janku et al. JOURNAL OF CLINICAL ONCOLOGY
- IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells
- (2009) L. Guo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy
- (2008) C. S. Hinrichs et al. BLOOD
- Activation of extracellular signaling regulated kinase in natural killer cells and monocytes following IL-2 stimulation in vitro and in patients undergoing IL-2 immunotherapy: analysis via dual parameter flow-cytometric assay
- (2008) Sri Vidya Kondadasula et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor-Specific T-Cell Memory: Clearing the Regulatory T-Cell Hurdle
- (2008) A. L. Cote et al. CANCER RESEARCH
- A Dose-Escalation Study of Recombinant Human Interleukin-18 Using Two Different Schedules of Administration in Patients with Cancer
- (2008) M. J. Robertson et al. CLINICAL CANCER RESEARCH
- Translational Research Working Group Developmental Pathway for Immune Response Modifiers
- (2008) M. A. Cheever et al. CLINICAL CANCER RESEARCH
- IFN- -2b-Induced Signal Transduction and Gene Regulation in Patient Peripheral Blood Mononuclear Cells Is Not Enhanced by a Dose Increase from 5 to 10 Megaunits/m2
- (2008) J. M. Zimmerer et al. CLINICAL CANCER RESEARCH
- Sunitinib Reverses Type-1 Immune Suppression and Decreases T-Regulatory Cells in Renal Cell Carcinoma Patients
- (2008) J. H. Finke et al. CLINICAL CANCER RESEARCH
- Focus on FOCIS: Interleukin 2 treatment associated autoimmunity
- (2008) Stergios J. Moschos et al. CLINICAL IMMUNOLOGY
- Roles of ubiquitination in pattern-recognition receptors and type I interferon receptor signaling
- (2008) Annie Bibeau-Poirier et al. CYTOKINE
- Immune modulation by melanoma-derived factors
- (2008) Dan Ilkovitch et al. EXPERIMENTAL DERMATOLOGY
- Interleukin-21: biology and application to cancer therapy
- (2008) David J Andorsky et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Phase I Study of Recombinant Interleukin-21 in Patients With Metastatic Melanoma and Renal Cell Carcinoma
- (2008) John A. Thompson et al. JOURNAL OF CLINICAL ONCOLOGY
- In Reply
- (2008) Meller P. Davis et al. JOURNAL OF CLINICAL ONCOLOGY
- Three Phase II Cytokine Working Group Trials of gp100 (210M) Peptide Plus High-Dose Interleukin-2 in Patients With HLA-A2–Positive Advanced Melanoma
- (2008) Jeffrey A. Sosman et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial Comparing Concurrent Biochemotherapy With Cisplatin, Vinblastine, Dacarbazine, Interleukin-2, and Interferon Alfa-2b With Cisplatin, Vinblastine, and Dacarbazine Alone in Patients With Metastatic Malignant Melanoma (E3695): A Trial Coordinated by the Eastern Cooperative Oncology Group
- (2008) Michael B. Atkins et al. JOURNAL OF CLINICAL ONCOLOGY
- Interleukin 21: combination strategies for cancer therapy
- (2008) Kresten Skak et al. NATURE REVIEWS DRUG DISCOVERY
- Distinct Effects of IL-18 on the Engraftment and Function of Human Effector CD8+ T Cells and Regulatory T Cells
- (2008) Richard G. Carroll et al. PLoS One
- Therapeutic vaccination with dendritic cells pulsed with tumor-derived Hsp70 and a COX-2 inhibitor induces protective immunity against B16 melanoma
- (2008) Deirdre Toomey et al. VACCINE
- The Biology of Interleukin-2
- (2007) Thomas R. Malek Annual Review of Immunology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now